Shimamura, Munehisa
Nakagami, Hironori
Shimizu, Hideo
Mukai, Hideyuki
Watanabe, Ryosuke
Okuzono, Takeshi
Kawano, Tomohiro
Ikeda, Yuka
Hayashi, Hiroki
Yoshida, Shota
Ju, Nan
Mochizuki, Hideki http://orcid.org/0000-0002-0874-7542
Morishita, Ryuichi
Article History
Received: 8 October 2018
Accepted: 9 November 2018
First Online: 11 December 2018
Competing Interests
: A patent application on the MHPs has been filed (application no. 2015-102502 and PCT/JP2016/064446; M.S., H.N., R.M.). The Department of Clinical Gene Therapy is financially supported by AnGes MG, Novartis, Shionogi, Boeringher, and Rohto. The Department of Health Development and Medicine is financially supported by AnGes MG and DAICEL. R.M. is a founder and stockholder of AnGes MG and a former board member. M.S. and H.N. are stockholders of MH peptide.